EyeCRO are Experts in preclinical efficacy studies in ophthalmic retinopathy, pharmacokinetics, both in vivo and in vitro for clinical and precise formulation services and trial batteries. EyeCRO is a preclinical ophthalmic research organization focused on studies in retina preclinical efficacy, oxygen-induced retinopathy, and ophthalmic pharmacokinetics for clinical and precise formulation services and trial batteries. EyeCRO is a preclinical ophthalmic research organization focused on studies in Laser CNV, Retina preclinical efficacy, and Ophthalmic toxicology for clinical and precise formulation services.

Web developed by Josh Bolinger website design

The Global Leader in Preclinical Ophthalmic Research

MiDROPS™

The Microemulsion Drug Ocular Penetration System (MiDROPS™) is a transformative technology for the development of eyedrop formulations.  This patented platform allows for the preparation and delivery of lipophilic agents to tissues in both the front and back of the eye.  MiDROPS™ are prepared using materials already approved by the US Food and Drug Administration for use in ophthalmic products, and by nature are intrinsically thermo-stable.

 

In-Vivo

EyeCRO provides numerous in-vivo research models to enable directed and meaningful preclinical drug discovery and development programs. EyeCRO also has extensive experience in various routes of administration and can customize studies depending on your needs. One of the main advantages in working with EyeCRO is our ability to be flexible.

Allergan Makes an Eye-Opening Acquisition

Global pharmaceutical company Allergan (NYSE:AGN) may have just revealed its plans for the future. … Read More

Curing blindness by repairing corneas with invisible films

The University of Melbourne–lead team of researchers have grown corneal cells on a layer of film … Read More

Interim results from clinical trial demonstrate safety of cell-based therapy for retinitis pigmentosa

Regenerative medicine company jCyte and the Sue & Bill Gross Stem Cell Research Center at the … Read More

More News

Tuesday, August 30th, 2016 at 5:46am
Study finds tight glycemic control provides no impact on patient-important microvascular outcomes https://t.co/zGVyQKVN1c
Tuesday, August 30th, 2016 at 5:42am
Drug-dispensing contact lens effectively lowers eye pressure in glaucoma model https://t.co/kQC4XpAEkC via @medical_xpress
Monday, August 29th, 2016 at 7:57am
Researchers find new role for cannabinoids in vision: Chemicals shown to improve low-light vision https://t.co/rK9QV2V2xL
Ophthalmic Contract Research